FDA Inspection 1087206 — L.A. UNIVERSAL RESEARCH CENTER Inc.
The FDA completed an inspection of L.A. UNIVERSAL RESEARCH CENTER Inc. on Apr 3, 2019 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 3, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Los Angeles, CA (United States)
Additional details
Clinical BA/BE